Strengthening pharmaceutical research, development in Nigeria
*NIPRD, Bloom Public Health partner to ensure availability of quality medicines during, post-COVID-19 pandemic
As part of emergency efforts to find medicines to prevent or treat the novel coronavirus (COVID-19) infection and strengthen pharmaceutical research and development to ensure the availability of quality medicines to all citizens of Nigeria during and post pandemic, the National Institute of Pharmaceutical Research and Development (NIPRD) Abuja is partnering with Bloom Public Health (Bloom) through a Memorandum of Understanding (MoU).
According to the MoU signed yesterday in Abuja, Bloom will facilitate other collaborations within Africa to support NIPRD in playing a leadership role in the pharmaceutical quality space. Additionally, Bloom will serve as NIPRD’s technical partner for accessing and implementing donor-funded initiatives to enhance NIPRD’s impact in Nigeria.
Chief Executive Officer (CEO), Bloom Public Health, Prof. Chimezie Anyakora, said, “The COVID-19 pandemic amplifies the urgent need to strengthen the Nigerian Pharmaceutical sector and NIPRD as an institution is extremely instrumental to the growth and development of the sector. This partnership will ensure that NIPRD is fully supported technically to lead our country’s pharmaceutical sector reform and we are honored and privileged to be able to contribute our quota to this great journey. The Bloom Public Health and NIPRD partnership will catalyze a pharmaceutical renaissance and we are looking forward to the impact it will have on public health.”
Director General, NIPRD, Dr. Obi Peter Adigwe, said: “The partnership between Bloom and NIPRD is the type of Africa-led collaboration that will revolutionise the development of home-grown solutions for our healthcare issues. With NIPRD being one of a kind in the Region and also statutorily charged with the responsibility for research and development of drugs, vaccines, phytomedicines and commodities, our strategic plan is to use carefully nurtured partnerships with institutions, Nigerian and foreign universities and funding agencies to stimulate local production of excipients, pharmaceutical inputs, quality medicines and other innovative interventions for the sector. We are glad to partner with Bloom Public Health as it is just the sort of contextual alliance that can expedite access to healthcare for our people.” According to the MoU, given the shared interest, both parties desire to work together on a mutual strategy of strengthening the health systems to guarantee access to safe and affordable health products for Nigerians. Anyakora said Bloom Public Health concept was born from the need to create strategic and operational solutions at the African level for public health problems, and particularly in the pharmaceutical sector. “For more information about us, visit www.bloompublichealth.com,” he said.